异动解读|晶泰控股盘中上涨7.28%,AI制药板块集体走强叠加平台发布催化

行情直击
Aug 10

8月10日,晶泰控股盘中上涨7.28%,报8.11港元,成交额3678.24万港元。

消息面上,公司近日正式发布XtalPi Science科学智能平台,并联合26家机构发起"科学智能开放生态联盟",市场对其估值逻辑由CRO服务商向AI平台型公司切换的预期升温。同时,摩根大通近期首予公司"增持"评级,浙商证券维持"买入"评级并指出剔除一次性管线影响后主业同比增长65%。此外,公司8月19日将召开董事会审议中期业绩,业绩窗口期临近亦提振资金关注。

板块层面,生命科学工具和服务行业今日整体走强,英矽智能涨9.6%、金斯瑞生物科技涨7.4%、药明生物涨5.02%,AI制药赛道资金共振明显。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10